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same	clinic	based	on	(a)	gender,	 (b)	 implant	region,	 (c)	smoking	status	and	(d)	bone	




male)	 receiving	1,517	 implants	were	 identified;	 10	patients	 had	one	EIL	 each	 (im‐
plant/patient	 level:	0.66/2.25%).	Splitting	 this	patient	cohort	additionally	 into	 four	
age	groups	[65–69.9	(n	=	213),	70–74.9	(n	=	111),	75–79.9	(n	=	80)	and	≥80	(n	=	40)],	
EIL	was	on	the	implant	level	0.41,	0.83,	0.34	and	2.26%,	respectively,	(p	=	.102)	and	






















































the	prognosis	 is	 that	 these	percentages	will	 continue	 to	grow	 in	
the	 future.	 Taking	 this	 into	 account,	 together	with	 the	 fact	 that	
implant‐supported	 restorations	 significantly	 improve	 not	 only	
oral	 health‐related	 quality	 of	 life	 (Reissmann,	 Dard,	 Lamprecht,	
Struppek,	 &	Heydecke,	 2017),	 but	 also	 health‐related	 quality	 of	
life	(Naito	et	al.,	2006)	in	general,	elderly	patients	seeking	implant	
treatment	 are	 and	 will	 remain	 a	 significant	 part	 of	 daily	 clinical	
work	(Schimmel,	Müller,	Suter,	&	Buser,	2017).	In	a	recent	system‐





previously	 reported	 for	 the	general	population;	 for	example,	 the	
survival	 rate	 of	 implants	 supporting	 single	 crowns	 is	 >97%	 and	
95%	after	5	and	10	years,	respectively,	and	that	of	implants	sup‐
porting	 fixed	 dental	 prostheses	 is	 >95%	 and	 93%,	 respectively	
(Hjalmarsson,	Gheisarifar,	&	Jemt,	2016;	Jung,	Zembic,	Pjetursson,	





In	 this	 context,	 several	 factors	 associated	 with	 ageing	 may	

















nal	 studies	 included	 in	 the	 above‐mentioned	 systematic	 reviews	
(Sendyk	 et	 al.,	 2017;	 Srinivasan	 et	 al.,	 2017),	 information	 on	EIL	
was	often	missing,	while	 the	number	of	 elderly	patients	 in	most	





2013).	 Consequently,	 lack	 of	 significant	 differences	 between	 el‐
derly	 and	younger	patients,	 in	 terms	of	 survival	 rates	of	 already	
















were	 performed	 in	 the	 Division	 of	 Oral	 Surgery,	 by	 experienced	




Scientific rationale for the study:	 Information	 on	 early	 im‐
plant	 loss	 (EIL;	 i.e.	 lack	of	osseointegration	prior	 to	or	 at	
the	 time‐point	 of	 prosthetic	 restoration)	 in	 the	 elderly	 is	
rather	scarce	in	the	currently	existing	literature.
Principal findings:	EIL	 in	patients	≥65	years	old	at	 implant	
installation	was	similarly	low	as	in	younger	patients	35	to	
<55	years	old	(1.44%	vs.	2.59%,	respectively),	matched	for	




level,	 respectively,	 compared	 with	 patients	 65–79	 years	
old	that	showed	rates	of	0.34%–0.83%	and	1.25%–1.70%,	























The	 following	parameters	were	extracted:	 (a)	age,	 (b)	gender,	
(c)	implant	region,	(d)	EIL,	that	is	lack	of	osseointegration	prior	to	
placement	of	the	prosthesis	and	occlusal	loading	(yes/no;	primary	
outcome	 variable),	 (e)	 bone	 augmentation	 prior	 to	 or	 simultane‐
ously	with	 implant	 installation	 (yes/no),	 (f)	 smoking	status	at	 the	
time‐point	of	implant	installation	(yes/no),	(g)	history	of	periodon‐
titis,	 that	 is	 presence	 of	 bone	 loss	 judged	 on	 panoramic	 radio‐
graphs	or	if	the	patient	was	completely	edentulous	(yes/no;	please	




thritis	 (yes/no)	and	 (i)	 regular	 intake	of	bisphosphonates,	 statins,	








age.	One	 implant	 in	 each	 elderly	 patient	was	 attempted	 to	match	
with	 an	 implant	 installed	 in	 a	 patient	 35	 to	 <55	 years	 old	 at	 the	
time‐point	 of	 implant	 installation,	 by	manually	 looking	 through	 an	
automatically	generated	list	of	dental	records	of	all	patients	who	had	
paid/received	an	 implant	at	 the	same	clinic	and	 timeframe,	on	 the	
basis	of	the	following	criteria:	(a)	gender,	(b)	implant	region	[i.e.	upper	
anterior	(tooth	no.	13–23)/upper	posterior/lower	anterior	(tooth	no.	




from	 the	 remaining	ones	 in	 the	 same	patient	was	again	 chosen	at	









time‐point,	respectively,	 (b)	 implant	dimension,	(c)	 implant	type,	(d)	
connection	type,	that	is	internal/external,	(e)	antibiotic	prescription	




Descriptive	 statistics	 were	 calculated	 for	 patient‐	 and	 implant‐re‐
lated	characteristics.	To	 identify	any	potential	differences/tenden‐
cies	 among	 the	 elderly	 and	 younger	 patients,	 both	 cohorts	 were	
sub‐classified	into	4	age	sub‐cohorts:	(a)	65–69.9/70–74.9/75–79.9/	
and	 ≥80	 years	 of	 age	 in	 the	 elderly	 group,	 and	 (b)	 35–39.9/40–








periodontitis,	 presence/absence	of	 a	 systemic	 disease,	medication	
intake).	Patient‐specific	parameters	have	been	compared	on	the	pa‐
tient	 level,	while	 implant‐specific	parameters	on	 the	 implant	 level.	







age	 and	 gender	 were	 considered	 a	 priori	 confounders.	 Statistical	














































patient	 cohort	 (Table	3	and	Appendix	S1).	 In	 regard	 to	 the	matched	
cohorts,	five	patients	in	the	elderly	group	versus	nine	patients	in	the	
younger	group	experienced	one	EIL	each,	that	is	1.44%	versus	2.59%,	
respectively	 (p	 =	 .280;	 Figure	 1).	 No	 statistically	 significant	 differ‐












this	 finding	 appears	 to	 correspond	 well	 to	 the	 currently	 existing	
TA B L E  1  Characteristics	of	the	elderly	patient	cohort	(n	=	444)	
and	implant‐specific	details	(n	=	1,517)
























































specifically	 addressed;	 in	 most	 of	 the	 original	 studies	 included	 in	
these	reviews,	information	on	EIL	was	often	missing,	while	the	num‐
ber	of	elderly	patients	was	in	general	rather	small	(i.e.	mostly	<50).	




osseous	wound	 healing,	 starting	with	 an	 inflammatory	 phase	 due	





and	 consequently,	 a	 prolonged	 inflammatory	phase	 is	 observed	 in	
the	 elderly	 compared	with	 younger	 patients.	 Further,	 the	 number	
and	function	of	stem	cells,	 including	growth	factor	production,	are	
decreased	with	increasing	age,	resulting	in	reduced	new	bone	tissue	
formation	 capacity	 and	 imbalanced	 remodelling,	which	 in	 turn	 af‐
fects	 tissue	maturation	 (Bartold	et	 al.,	2016;	Bosshardt,	Chappuis,	
&	Buser,	2017;	Chan	&	Duque,	2002;	Gibon,	Lu,	&	Goodman,	2016).	
 
Young patient cohort 
(<55 years of age)
Elderly patient cohort 
































Upper	posterior/anterior 94	(27.1)/24	(6.9)  
Lower	posterior/anterior 200	(57.6)/29	(8.4)  
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History	of	periodontitis	(no/yes;	n) 60/374 0/10 .371
Systemic	disease	(no/yes;	n)
Diabetes	mellitus 388/46 9/1 1.000
Osteoporosis 393/41 10/0 .609
Rheumatoid	arthritis 414/20 10/0 1.000
Medication	intake	(no/yes;	n)
Bisphosphonates 403/31 10/0 1.000
Statins 342/92 8/2 1.000
Selective	serotonin	reuptake	inhibitors 386/48 10/0 .610
Proton‐pump	inhibitors 369/65 9/1 1.000
Anticonvulsants 418/16 10/0 1.000
Corticosteroids 411/23 10/0 1.000
Antihypertensives 240/194 6/4 1.000
Anticoagulants 403/31 10/0 1.000
Non‐steroidal	anti‐inflammatory	drugs 318/116 10/0 .070




Bone	augmentation	(no/yes;	n) 1,280/227 9/1 1.000
Abbreviation:	EIL,	early	implant	loss.
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Indeed,	 it	 has	 been	 demonstrated	 in	 preclinical	 trials	 that	 osse‐
ointegration	can	be	compromised	in	older	age	(Shirota	et	al.,	1993;	
Takeshita,	Murai,	 Ayukawa,	 &	 Suetsugu,	 1997).	 For	 example,	 tita‐
nium	implants	placed	in	the	tibia	of	old	rats	(1.5	years	old)	showed	










illary	 site,	 male	 gender,	 short	 implant	 length,	 implant	 type/brand,	
number	of	 implants,	 immediate	placement,	 need	of	bone	grafting,	
non‐submerged	 healing,	 history	 of	 periodontitis,	 the	 clinician	 and	
specific	 medication	 intake	 (Alsaadi,	 Quirynen,	 Komárek,	 &	 van	
Steenberghe,	2007;	Antoun,	Karouni,	Abitbol,	Zouiten,	&	Jemt,	2017;	
Berglundh,	Persson,	&	Klinge,	2002;	Bryant,	1998;	Chrcanovic,	Kisch,	
Albrektsson,	 &	 Wennerberg,	 2016;	 Derks	 et	 al.,	 2015;	 Esposito,	
Grusovin,	 Loli,	 Coulthard,	 &	 Worthington,	 2010;	 Hickin,	 Shariff,	
Jennette,	 Finkelstein,	 &	 Papapanou,	 2017;	 Jemt,	 2017;	 Manzano	
et	al.,	2016;	Olate,	Lyrio,	de	Moraes,	Mazzonetto,	&	Moreira,	2010;	
Olmedo‐Gaya,	Manzano‐Moreno,	Cañaveral‐Cavero,	Dios	Luna‐del	
Castillo,	 &	 Vallecillo‐Capilla,	 2016;	 Palma‐Carrió,	 Maestre‐Ferrín,	
Peñarrocha‐Oltra,	 Peñarrocha‐Diago,	 &	 Peñarrocha‐Diago,	 2011;	













data	 on	 the	 reason	of	 tooth	 loss	 for	 each	 single	 tooth	 cannot	 ex‐
clude	the	possibility	that	some/several	of	the	teeth	were	lost	due	to	
TA B L E  4  Frequency	distribution	of	the	various	patient‐	and	implant‐related	parameters	in	EIL	and	non‐EIL	cases,	in	the	matched	patient	
cohorts
Patient and implant characteristics
Elderly patient cohort 
(≥65 years of age)  
Early implant loss
p‐value
Younger patient cohort 
(<55 years of age)  
Early implant loss
p‐valueNo (n = 342) Yes (n = 5) No (n = 338) Yes (n = 9)
Age	cohortsa	(n) 168/103/49/22 3/1/0/1 .499 54/72/92/120 2/3/0/4 .328
Gender	(female/male;	n) 193/149 1/4 .174 189/149 5/4 1.000
Smoking	status	at	the	time‐point	of	implant	instal‐
lation	(non‐smoker/smoker;	n)
299/43 4/1 .494 296/42 7/2 .319
History	of	periodontitis	(no/yes;	n) 33/309 0/5 1.000 229/109 4/5 .161
Systemic	disease	(no/yes;	n)
Diabetes	mellitus 305/37 5/0 1.000 335/3 9/0 1.000
Osteoporosis 314/28 5/0 1.000 337/1 9/0 1.000
Rheumatoid	arthritis 324/18 5/0 1.000 337/1 9/0 1.000
Medication	intake	(no/yes;	n)
Bisphosphonates 319/23 5/0 1.000 337/1 9/0 1.000
Statins 271/71 5/0 .588 329/9 9/0 1.000
Selective	serotonin	reuptake	inhibitors 304/38 5/0 1.000 327/11 9/0 1.000
Proton‐pump	inhibitors 298/44 5/0 1.000 330/8 9/0 1.000
Anticonvulsants 331/11 5/0 1.000 335/3 9/0 1.000
Corticosteroids 321/21 5/0 1.000 328/10 9/0 1.000
Antihypertensives 191/151 4/1 .391 303/35 8/1 1.000
Anticoagulants 315/27 5/0 1.000 336/2 9/0 1.000
Non‐steroidal	anti‐inflammatory	drugs 257/85 5/0 .340 330/8 8/1 .213
Implant	region	(upper	posterior/upper	anterior/
lower	posterior/lower	anterior;	n)
92/23/199/28 2/1/1/1 .303 93/23/194/28 1/1/6/1 .724
Bone	augmentation	(no/yes;	n) 277/65 5/0 .588 274/64 8/1 1.000
aElderly	patient	cohort:	65–69.9/70–74.9/75–79.9/>80	years	of	age;	Younger	patient	cohort:	35–39.9/40–44.9/45–49.9/50–54.9	years	of	age.	









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































edentulous	 patients	 suffered	 from	 some	 degree	 of	 periodontitis.	
Nevertheless,	other	 factors	 largely	 inherent	with	ageing	could	not	






population,	 none	 of	 the	 investigated	 systemic	 diseases	 appeared	
in	>1%	and	none	of	the	medications	was	taken	by	more	than	3.5%	
of	the	patients,	except	of	antihypertensives	(10%);	so,	the	younger	











groups	 for	4	conceptually	 relevant	parameters	 (i.e.	gender,	 region,	
smoking,	augmentation).	Further,	the	extent	of	therapy	(i.e.	number	
of	 implants	 installed)	was	 not	 considered	 during	matching	 herein,	
because	it	was	anticipated	that	a	large	number	of	patients	would	not	
be	able	to	match,	due	to	the	fact	that	younger	patients	would	most	





with	age	as	 the	 independent	 factor	and	correcting	 for	 the	various	
parameters,	or	perform	hierarchical	analyses	 including	all	 implants	
of	a	patient.
In	 this	 context,	 the	 elderly	 patients	 herein	 cannot	 be	 consid‐










































Considering	 the	 facts/limitations	 that	 the	 present	 study	 is	 of	
retrospective	 character,	 both	 elderly	 and	 younger	 patient	 groups	
were	 relatively	 healthy,	 the	 operators	 were	 experienced	 oral	 sur‐
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